Company news

EMV Capital PLC news in 2025

EMV Capital PLC's news releases, calls and decks from 2025, newest first.

View company

Sofant Technologies: Fundraising

December 23, 2025

Director/PDMR Dealing

December 19, 2025

Wanda Health: Fundraising and Business Update

December 10, 2025

Share Issue, PDMR Dealings & Total Voting Rights

December 8, 2025

TR-1

December 4, 2025

Expansion of Senior Finance Leadership Team

November 24, 2025

Portfolio Update

November 20, 2025

Interim Results and Investor Presentation

September 30, 2025

Asset Purchase Agreement with Destiny Pharma

September 22, 2025

Notice of Interim Results

September 18, 2025

Result of AGM

June 30, 2025

Office move and Related Party Transaction

June 30, 2025

Q-Bot Limited Fundraising

June 27, 2025

Notice of AGM and Annual Report & Accounts

June 6, 2025

Director/PDMR Shareholding

June 4, 2025

Preliminary results for the year ended 31 Dec 2024

June 4, 2025

PDS: Q1 Results and Clinical and Corporate Update

May 14, 2025

PDS: Q4 Results and Clinical Programs Update

March 27, 2025

PDS: VERSATILE-003 Phase 3 Clinical Trial

March 7, 2025

PDS: up to $22mn Registered Direct Offering

February 27, 2025

PDS Biotech reaffirms guidance for clinical trial

February 5, 2025

ProAxsis: Status Update and Proposed Fundraise

February 3, 2025

Calls in 2025

Decks in 2025